Afuco™ Anti-Human CD4 ADCC Therapeutic Antibody (M-T413), ADCC Enhanced
Anti-CD4 ADCC Enhanced Antibody (M-T413) is an ADCC enhanced antibody produced by our Afuco™ platform. This is an anti-CD4 monoclonal antibodies (mAbs) that have shown considerable promise in the treatment of rheumatoid arthritis, psoriasis, and allograft rejection and may have potential use in blocking HIV-1 infection.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-119CL |
| Pricing | Inquiry |
| Host | Chimeric (human/mouse) |
| Target | CD4 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C for long-term storage. Store at 4°C for up to one month. Avoid freeze/thaw cycles. |